Rezultati - Evidio Domingo‐Musibay

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Oncolytic measles virus strains as novel anticancer agents

    Oncolytic measles virus strains as novel anticancer agents od Pavlos Msaouel, Mateusz Opyrchal, Evidio Domingo‐Musibay, Evanthia Galanis

    Izdano 2013
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients

    Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients od Can Özütemiz, Luke A. Krystosek, An L. Church, Anil Chauhan, Jutta Ellermann, Evidio Domingo‐Musibay, Daniel Steinberger

    Izdano 2021
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Oncolytic measles virus strains have significant antitumor activity against glioma stem cells

    Oncolytic measles virus strains have significant antitumor activity against glioma stem cells od Cory Allen, Mateusz Opyrchal, Ileana Aderca, Mark A. Schroeder, Jann N. Sarkaria, Evidio Domingo‐Musibay, Mark J. Federspiel, Evanthia Galanis

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma

    Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma od Evidio Domingo‐Musibay, Paari Murugan, Alessio Giubellino, Sandeep Sharma, Daniel Steinberger, Jianling Yuan, Matthew A. Hunt, Emil Lou, Jeffrey S. Miller

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

    Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma od Amod A. Sarnaik, Omid Hamid, Nikhil I. Khushalani, Karl D. Lewis, Theresa Medina, Harriet M. Kluger, Sajeve Thomas, Evidio Domingo‐Musibay, Anna C. Pavlick, Eric D. Whitman, Salvador Martín‐Algarra, Pippa Corrie, Brendan D. Curti, Judit Oláh, Jose Lutzky, Jeffrey S. Weber, James Larkin, Wen Shi, Toshimi Takamura, Madan Jagasia, Harry Qin, Xiao Wu, Cécile Chartier, Friedrich Graf Finckenstein, Maria Fardis, John M. Kirkwood, Jason Chesney

    Izdano 2021
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study

    Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint... od Jason Chesney, Karl D. Lewis, Harriet M. Kluger, Omid Hamid, Eric D. Whitman, Sajeve Thomas, Martin Wermke, Mike Cusnir, Evidio Domingo‐Musibay, Giao Q. Phan, John M. Kirkwood, Jessica C. Hassel, Marlana Orloff, James Larkin, Jeffrey S. Weber, Andrew J.S. Furness, Nikhil I. Khushalani, Theresa Medina, Michael E. Egger, Friedrich Graf Finckenstein, Madan Jagasia, Parameswaran Hari, Giri Sulur, Wen Shi, Xiao Wu, Amod A. Sarnaik

    Izdano 2022
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial

    Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial od Tina J. Hieken, Garth D. Nelson, Thomas J. Flotte, Eric P. Grewal, Jun Chen, Robert R. McWilliams, Lisa A. Kottschade, Lu Yang, Evidio Domingo‐Musibay, Roxana Dronca, Yiyi Yan, Svetomir N. Markovic, Anastasios Dimou, Heather N. Montane, Courtney L. Erskine, Mara A. Piltin, Daniel L. Price, Samir S. Khariwala, Jane Yuet Ching Hui, Carrie Strand, Susan M. Harrington, Vera J. Suman, Haidong Dong, Matthew S. Block

    Izdano 2024
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: